In the UK, the National Institute for Health and Care Excellence (NICE) and also worldwide the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines on the diagnosis, monitoring and management of CKD do not recommend routine cystatin C measurement in everyone. The gene discussed is CST3; the disease is chronic kidney disease.